BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 29433446)

  • 1. Homocysteine is a bystander for ST-segment elevation myocardial infarction: a case-control study.
    Chen CJ; Yang TC; Chang C; Lu SC; Chang PY
    BMC Cardiovasc Disord; 2018 Feb; 18(1):33. PubMed ID: 29433446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Admission homocysteine is an independent predictor of spontaneous reperfusion and early infarct-related artery patency before primary percutaneous coronary intervention in ST-segment elevation myocardial infarction.
    Li J; Zhou Y; Zhang Y; Zheng J
    BMC Cardiovasc Disord; 2018 Jun; 18(1):125. PubMed ID: 29940881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between serum homocysteine levels and long-term outcomes in patients with ST-segment elevation myocardial infarction.
    Si J; Li XW; Wang Y; Zhang YH; Wu QQ; Zhang LM; Zuo XB; Gao J; Li J
    Chin Med J (Engl); 2019 May; 132(9):1028-1036. PubMed ID: 30829711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Factors for In-Hospital and Long-Term Survival in Patients with Acute ST-Segment Elevation Myocardial Infarction after Percutaneous Coronary Intervention.
    Hou LL; Gao C; Feng J; Chen ZF; Zhang J; Jiang YJ; Li XX; Wang BN
    Tohoku J Exp Med; 2017 May; 242(1):27-35. PubMed ID: 28496014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of serum transaminases with short- and long-term outcomes in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Gao M; Cheng Y; Zheng Y; Zhang W; Wang L; Qin L
    BMC Cardiovasc Disord; 2017 Jan; 17(1):43. PubMed ID: 28129742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of serum uric acid and Killip class on mortality after acute ST-segment elevation myocardial infarction and primary percutaneous coronary intervention.
    Liu CW; Liao PC; Chen KC; Chiu YW; Liu YH; Ke SR; Wu YW
    Int J Cardiol; 2017 Jan; 226():26-33. PubMed ID: 27780079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating HtrA2 as a novel biomarker for mitochondrial induced cardiomyocyte apoptosis and ischemia-reperfusion injury in ST-segment elevation myocardial infarction.
    Hortmann M; Robinson S; Mohr M; Haenel D; Mauler M; Stallmann D; Reinoehl J; Duerschmied D; Peter K; Bode C; Ahrens I
    Int J Cardiol; 2017 Sep; 243():485-491. PubMed ID: 28602551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relation of Circulating Trimethylamine N-Oxide With Coronary Atherosclerotic Burden in Patients With ST-segment Elevation Myocardial Infarction.
    Sheng Z; Tan Y; Liu C; Zhou P; Li J; Zhou J; Chen R; Chen Y; Song L; Zhao H; Yan H
    Am J Cardiol; 2019 Mar; 123(6):894-898. PubMed ID: 30594289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated plasma S100A1 level is a risk factor for ST-segment elevation myocardial infarction and associated with post-infarction cardiac function.
    Fan L; Liu B; Guo R; Luo J; Li H; Li Z; Xu W
    Int J Med Sci; 2019; 16(8):1171-1179. PubMed ID: 31523180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma apelin-12 levels may predict in-hospital major adverse cardiac events in ST-elevation myocardial infarction and the relationship between apelin-12 and the neutrophil/lymphocyte ratio in patients undergoing primary coronary intervention.
    Topuz M; Oz F; Akkus O; Sen O; Topuz AN; Bulut A; Ozbicer S; Okar S; Koc M; Gur M
    Perfusion; 2017 Apr; 32(3):206-213. PubMed ID: 27770057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current characteristics and management of ST elevation and non-ST elevation myocardial infarction in the Tokyo metropolitan area: from the Tokyo CCU network registered cohort.
    Miyachi H; Takagi A; Miyauchi K; Yamasaki M; Tanaka H; Yoshikawa M; Saji M; Suzuki M; Yamamoto T; Shimizu W; Nagao K; Takayama M
    Heart Vessels; 2016 Nov; 31(11):1740-1751. PubMed ID: 26758733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation of inflammatory markers with myocardial and microvascular injury in patients with reperfused ST-elevation myocardial infarction.
    Reindl M; Reinstadler SJ; Feistritzer HJ; Klug G; Tiller C; Mair J; Mayr A; Jaschke W; Metzler B
    Eur Heart J Acute Cardiovasc Care; 2017 Oct; 6(7):640-649. PubMed ID: 27440935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of plasma 25-(OH) vitamin D levels in acute ST elevation myocardial infarction.
    Şen Ö; Topuz M; Acele A; Akkuş O; Baykan AO; Koç M
    Cardiol J; 2017; 24(6):677-684. PubMed ID: 28612906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-37 increased in patients with acute coronary syndrome and associated with a worse clinical outcome after ST-segment elevation acute myocardial infarction.
    Liu K; Tang Q; Zhu X; Yang X
    Clin Chim Acta; 2017 May; 468():140-144. PubMed ID: 28237549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COLIN trial: Value of colchicine in the treatment of patients with acute myocardial infarction and inflammatory response.
    Akodad M; Lattuca B; Nagot N; Georgescu V; Buisson M; Cristol JP; Leclercq F; Macia JC; Gervasoni R; Cung TT; Cade S; Cransac F; Labour J; Dupuy AM; Roubille F
    Arch Cardiovasc Dis; 2017; 110(6-7):395-402. PubMed ID: 28065445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating Sulfatide, A Novel Biomarker for ST-Segment Elevation Myocardial Infarction.
    Li G; Hu R; Guo Y; He L; Zuo Q; Wang Y
    J Atheroscler Thromb; 2019 Jan; 26(1):84-92. PubMed ID: 29887538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensive atorvastatin improves endothelial function and decreases ADP-induced platelet aggregation in patients with STEMI undergoing primary PCI: A single-center randomized controlled trial.
    Xu X; Liu Y; Li K; Wang P; Xu L; Yang Z; Yang X
    Int J Cardiol; 2016 Nov; 222():467-472. PubMed ID: 27505335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eroded Versus Ruptured Plaques at the Culprit Site of STEMI: In Vivo Pathophysiological Features and Response to Primary PCI.
    Saia F; Komukai K; Capodanno D; Sirbu V; Musumeci G; Boccuzzi G; Tarantini G; Fineschi M; Tumminello G; Bernelli C; Niccoli G; Coccato M; Bordoni B; Bezerra H; Biondi-Zoccai G; Virmani R; Guagliumi G;
    JACC Cardiovasc Imaging; 2015 May; 8(5):566-575. PubMed ID: 25890582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-12 serum level has prognostic value in patients with ST-segment elevation myocardial infarction.
    Zykov MV; Barbarash OL; Kashtalap VV; Kutikhin AG; Barbarash LS
    Heart Lung; 2016; 45(4):336-40. PubMed ID: 27094852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial function after ST-elevation myocardial infarction in patients with high levels of high-sensitivity CRP and Lp-PLA
    Kandhai-Ragunath JJ; de Wagenaar B; Doelman C; van Es J; Jørstad HT; Peters RJG; Doggen CJM; von Birgelen C
    Cardiovasc Revasc Med; 2017; 18(3):202-206. PubMed ID: 28110894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.